Credit: Zhen Ma, University of California, Berkeley
Last Posted: Dec 06, 2018
- FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care
FDA Press Release, December 4, 2018 - Hypertrophic cardiomyopathy: A complex disease.
Young Laura et al. Cleveland Clinic journal of medicine 2018 May 85(5) 399-411 - A targeted next-generation gene panel reveals a novel heterozygous nonsense variant in TP63 gene in Arrhythmogenic Cardiomyopathy patients.
Poloni Giulia et al. Heart rhythm 2018 Nov - Arrhythmogenic Cardiomyopathy in 2018: ARVC/ALVC or Both?
Bennett Richard G et al. Heart, lung & circulation 2018 Oct - Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations.
Domínguez Fernando et al. Journal of the American College of Cardiology 2018 Nov 72(20) 2471-2481 - Genetic Testing and Counseling for Hypertrophic Cardiomyopathy.
Cirino Allison L et al. Cardiology clinics 2019 Feb 37(1) 35-43 - The Clinical Course of a Genetic Dilated Cardiomyopathy: Letting the Cat Out of the BAG3.
Shaw Robin M et al. Journal of the American College of Cardiology 2018 Nov 72(20) 2482-2484 - Hypertrophic Cardiomyopathy Without Ventricular Hypertrophy: Usefulness of Genetic and Pathological Study in Preventing Sudden Death.
Segura-Villalobos Federico et al. Revista espanola de cardiologia (English ed.) 2017 Jul 70(7) 604-606 - Modeling Hypertrophic Cardiomyopathy in a Dish
NIH Director's Blog, November 8, 2018 - The genetics of hypertrophic cardiomyopathy.
Akhtar Mohammed et al. Global cardiology science & practice 2018 Aug 2018(3) 36
No hay comentarios:
Publicar un comentario